Kartos Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Kartos Therapeutics's estimated annual revenue is currently $13.6M per year.(i)
  • Kartos Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Kartos Therapeutics has 88 Employees.(i)
  • Kartos Therapeutics grew their employee count by -21% last year.

Kartos Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Scientific Officer at Kartos TherapeuticsReveal Email/Phone
3
SVP FinanceReveal Email/Phone
4
VP, Head Programming and Data OperationsReveal Email/Phone
5
SVP Clinical Development OperationsReveal Email/Phone
6
VP, Medical Affairs, The Americas and Asia-PacReveal Email/Phone
7
SVP - Strategy & Business DevelopmentReveal Email/Phone
8
VP, Medical WritingReveal Email/Phone
9
VP, Toxicology and Experimental MedicineReveal Email/Phone
10
VP, Translational ScienceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Kartos Therapeutics?

Kartos Therapeutics is a privately held, clinical-stage biopharmaceutical company developing a potentially best-in-class MDM2 inhibitor. Launched in 2018 by proven industry veterans, we are a passionate team based in Redwood City, California, and Bellevue, Washington. We have brought together scientists and clinicians with a deep understanding of hematology and oncology and an experienced leadership team. Together, we’re building an exciting biotechnology company with a culture defined by caring, ambition, dedication, and teamwork!

keywords:N/A

N/A

Total Funding

88

Number of Employees

$13.6M

Revenue (est)

-21%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M886%N/A
#2
$12.9M89N/AN/A
#3
$18.4M91-31%$17.8M
#4
$3.5M9311%N/A
#5
$15M946%N/A